Abstract
“Free radicals” is the term commonly used for molecules or ions that contain an odd number of electrons. The unavoidable presence of (at least) one unpaired electron has an enormous impact on the chemical reactivity of free radicals. They react very fast with non-radical species by either abstraction of an electron (acting as an oxidizing agent), donation of an electron (acting as a reducing agent), or by attachment to the non-radical (Slater, Biochem J 222:1–5, 1984). The product formed in the latter case (commonly termed secondary radical) also contains an unpaired electron, and hence may react with another non-radical and propagate a chain reaction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
When conducting blood tests the value measured is the amount of cholesterol in LDL and HDL (LDL-C and HDL-C, respectively), and so higher values are related to the cholesterol rich LDL (typically two to threefold more than for HDL), although on a molar basis the concentration of HDL is much higher (see Table 4.1, p. 50).
References
Slater, T.F.: Free-radical mechanisms in tissue injury. Biochem. J. 222, 1–15 (1984)
Cadenas, E.: Basic mechanisms of antioxidant activity. BioFactors 6, 391–397 (1997)
Finkel, T., Holbrook, N.J.: Oxidants, oxidative stress and the biology of ageing. Nature 408, 239–247 (2000)
Fridovich, I.: Superoxide radical: an endogenous toxicant. Annu. Rev. Pharmacol. Toxicol. 23, 239–257 (1983)
Griendling, K.K., Sorescu, D., Ushio-Fukai, M.: NAD(P)H oxidase : role in cardiovascular biology and disease. Circul. Res. 86, 494–501 (2000)
Pagano, P.J., et al.: An NADPH oxidase superoxide-generating system in the rabbit aorta. Am. J. Physiol. 268, H2274–H2280 (1995)
Fridovich, I.: Superoxide dismutases. Annu. Rev. Biochem. 44, 147–159 (1975)
Chance, B., Sies, H., Boveris, A.: Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527–605 (1979)
Fleming, I., Busse, R.: Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am. J. Physiol. 284, R1–R12 (2003)
Vásquez-Vivar, J., et al.: Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. USA 95, 9220–9225 (1998)
Kelm, M., Dahmann, R., Wink, D., Feelisch, M.: The nitric oxide/superoxide assay. J. Biol. Chem. 272, 9922–9932 (1997)
Pacher, P., Beckman, J.S., Liaudet, L.: Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315–424 (2007)
Ducrocq, C., Blanchard, B.: Peroxynitrite: an endogenous oxidizing and nitrating agent. Cell. Mol. Life Sci. 55, 1068–1077 (1999)
Ross, R.: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801–809 (1993)
Glass, C.K., Witztum, J.L.: Atherosclerosis: the road ahead. Cell 104, 503–516 (2001)
Brown, M.S., Goldstein, J.L.: The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89, 331–340 (1997)
Stocker, R., Keaney, J.F.: New insights on oxidative stress in the artery wall. J. Thromb. Haemost. 3, 1825–1834 (2005)
Palinski, W., et al.: Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA 86, 1372–1376 (1989)
Nishi, K., et al.: Oxidized LDL in carotid plaques and plasma associates with plaque instability. Atert. Thromb. Vasc. Biol. 22, 1649–1654 (2002)
Ehara, S., et al.: Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103, 1955–1960 (2001)
Aviram, M., Fuhrman, B.: LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants. Mol. Cell. Biochem. 188, 149–159 (1998)
Leeuwenburgh, C., et al.: Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272, 1433–1436 (1997)
Kontush, A., Chapman, M.J.: Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 58, 342–374 (2006)
Kontush, A., Chapman, M.J.: Antiatherogenic small, dense HDL—guardian angel of the arterial wall? Nat. Clin. Pract. Cardiovasc. Med. 3, 144–153 (2006)
Aviram, M., Rosenblat, M.: Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic. Biol. Med. 37, 1304–1316 (2004)
Nakajima, T., et al.: Characterization of the epitopes specific for the monoclonal antibody 9F5-3a and quantification of oxidized HDL in human plasma. Ann. Clin. Biochem. 41, 309–315 (2004)
Zheng, L., et al.: Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J. Clin. Invest. 114, 529–541 (2004)
Francis, G.A.: High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1483, 217–235 (2000)
Grundy, S.M., et al.: Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 110, 227–239 (2004)
Lenfant, C.: Clinical research to clinical practice—lost in translation? N. Engl. J. Med. 349, 868–874 (2003)
Steinberg, D., Glass, C.K., Witztum, J.L.: Evidence mandating earlier and more aggressive treatment of hypercholesterolemia. Circulation 118, 672–677 (2008)
Waters, D.D., et al.: Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. J. Am. Coll. Cardiol. 57, 1535–1545 (2011)
Preiss, D., et al.: Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy. JAMA J. Am. Med. Assoc. 305, 2556–2564 (2011)
Rietjens, I.M.C.M., et al.: The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environ. Toxicol. Pharmacol. 11, 321–333 (2002)
Fuhrman, B., Aviram, M.: Anti-atherogenicity of nutritional antioxidants. IDrugs 4, 82–92 (2001)
Steinhubl, S.R.: Why have antioxidants failed in clinical trials? Am. J. Cardiol. 101, 14D–19D (2008)
Bjelakovic, G., Nikolova, D., Gluud, L.L., Simonetti, R.G., Gluud, C.: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention—Systematic review and meta-analysis. JAMA, J. Am. Med. Assoc. 297, 842–857 (2007)
Gross, Z., Galili, N., Saltsman, I.: The first direct synthesis of corroles from pyrrole. Angew. Chem., Int. Ed. 38, 1427–1429 (1999)
Mahammed, A., Goldberg, I., Gross, Z.: Highly selective chlorosulfonation of tris(pentafluorophenyl)corrole as a synthetic tool for the preparation of amphiphilic corroles and metal complexes of planar chirality. Org. Lett. 3, 3443–3446 (2001)
Saltsman, I., et al.: Selective substitution of corroles: nitration, hydroformylation, and chlorosulfonation. J. Am. Chem. Soc. 124, 7411–7420 (2002)
Haber, A., Aviram, M., Gross, Z.: Protecting the beneficial functionality of lipoproteins by 1-Fe, a corrole-based catalytic antioxidant. Chem. Sci. 2, 295–302 (2011)
Kanamori, A., Catrinescu, M.M., Mahammed, A., Gross, Z., Levin, L.A.: Neuroprotection against superoxide anion radical by metallocorroles in cellular and murine models of optic neuropathy. J. Neurochem. 114, 488–498 (2010)
Kupershmidt, L., et al.: Metallocorroles as cytoprotective agents against oxidative and nitrative stress in cellular models of neurodegeneration. J. Neurochem. 113, 363–373 (2010)
Okun, Z., et al.: Manganese corroles prevent intracellular nitration and subsequent death of insulin-producing cells. ACS Chem. Biol. 4, 910–914 (2009)
Haber, A., et al.: Amphiphilic/bipolar metallocorroles that catalyze the decomposition of reactive oxygen and nitrogen species, rescue lipoproteins from oxidative damage, and attenuate atherosclerosis in mice. Angew. Chem. Int. Ed. 47, 7896–7900 (2008)
Agadjanian, H., et al.: Tumor detection and elimination by a targeted gallium corrole. Proc. Natl. Acad. Sci. USA 106, 6105–6110 (2009)
Agadjanian, H., et al.: Specific delivery of corroles to cells via noncovalent conjugates with viral proteins. Pharm. Res. 23, 367–377 (2006)
Aviv, I., Gross, Z.: Corrole-based applications. Chem. commun. (20), 1987–1999 (2007)
Gross, Z., Gray, H.B.: How do corroles stabilize high valent metals? Comments Inorg. Chem. 27, 61–72 (2006)
Simonson, S.G., et al.: Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. I. Physiology and biochemistry. J. Appl. Physiol. 83, 550–558 (1997)
Salvemini, D., Wang, Z.-Q., Stern, M.K., Currie, M.G., Misko, T.P.: Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proc. Natl. Acad. Sci. USA 95, 2659–2663 (1998)
Batinić-Haberle, I., Rebouças, J.S., Spasojević, I.: Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential. Antioxid. Redox Signal. 13, 877–918 (2010)
Eckshtain, M., et al.: Superoxide dismutase activity of corrole metal complexes. Dalton Trans. (38), 7879–7882 (2009)
Mahammed, A., Gross, Z.: Highly efficient catalase activity of metallocorroles. Chem. Comm. 46, 7040–7042 (2010)
Mahammed, A., Gross, Z.: Iron and manganese corroles are potent catalysts for the decomposition of peroxynitrite. Angew. Chem. Int. Ed. 45, 6544–6547 (2006)
Lee, J., Hunt, J.A., Groves, J.T.: Manganese porphyrins as redox-coupled peroxynitrite reductases. J. Am. Chem. Soc. 120, 6053–6061 (1998)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Haber, A. (2012). Introduction. In: Metallocorroles for Attenuation of Atherosclerosis. Springer Theses. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-30328-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-30328-9_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-30327-2
Online ISBN: 978-3-642-30328-9
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)